Latest Breaking News On - Marcos brindicci - Page 8 : comparemela.com

The interim trial results of Sputnik V, the coronavirus vaccine developed by Russia, are in, and results are showing 91.6 percent effectiveness in preventing symptomatic cases, as reported by CNN. There were no severe adverse events that appeared to be associated with the vaccine and the only side effects reported being mild, consisting of flu-like symptoms, pain at the injection site and low energy. Following the phase three trial of the vaccine, interim data suggests that two doses of Sputnik V reach a comparable level of effectiveness to those developed by Pfizer and Moderna. It also appears to provide a similar level of protection to those over 60. The data was gathered through a study involving almost 20,000 participants, with three-quarters receiving the vaccine and one-quarter receiving a placebo.

Marcos brindicci gettyAlexander edwardsReading school of pharmacyRussian direct investment fundUniversity of readingBiomedical technologyReading schoolIsidoro iriarte hospitalMarcos brindicciஅலெக்சாண்டர் எட்வர்ட்ஸ்ரீடிஂக் பள்ளி ஆஃப் மருந்தகம்ரஷ்ய நேரடி முதலீடு நிதிபல்கலைக்கழகம் ஆஃப் ரீடிஂக்உயிர் மருத்துவ தொழில்நுட்பம்ரீடிஂக் பள்ளிஐசிடோரோ இரியர்தே மருத்துவமனை